EMA starts rolling review for Moderna's COVID-19 vaccine candidate

Reuters
Moderna's logo is reflected in a drop on a syringe needle in this illustration

(Reuters) - Europe's health regulator said on Monday it had started a real-time review of Moderna Inc's <MRNA.O> experimental vaccine for COVID-19, on the back of similar such review launches for vaccines from AstraZeneca <AZN.L> and Pfizer <PFE.N>.

The European Medicines Agency's human medicines committee has started a "rolling review" for Moderna's mRNA-1273 vaccine candidate and has already started evaluating the first batch of data, the regulator said.

(Reporting by Aakash Jagadeesh Babu in Bengaluru; Editing by Sriraj Kalluvila)